We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-6.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$10.4B
AUM Growth
-$1.52B
Cap. Flow
-$723M
Cap. Flow %
-6.93%
Top 10 Hldgs %
32.83%
Holding
1,239
New
73
Increased
466
Reduced
278
Closed
97

Top Buys

Rank Stock Value
1
SITC icon
SITE Centers
SITC
+$150M
2
AMT icon
American Tower
AMT
+$128M
3
IRM icon
Iron Mountain
IRM
+$127M
4
SBAC icon
SBA Communications
SBAC
+$124M
5
PSA icon
Public Storage
PSA
+$113M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$211M
2
SPG icon
Simon Property Group
SPG
+$184M
3
HR icon
Healthcare Realty
HR
+$174M
4
DLR icon
Digital Realty Trust
DLR
+$163M
5
OHI icon
Omega Healthcare
OHI
+$160M

Sector Composition

Rank Sector Weight
1 Real Estate 74.77%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
1001
Crinetics Pharmaceuticals
CRNX
$8.86B
$7K ﹤0.01%
+220
New +$6.19K
CRSP icon
1002
CRISPR Therapeutics
CRSP
$4.58B
$7K ﹤0.01%
254
– –
DBC icon
1003
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$7K ﹤0.01%
500
– –
ENTA icon
1004
Enanta Pharmaceuticals
ENTA
$372M
$7K ﹤0.01%
105
– –
ESPR
1005
DELISTED
Esperion Therapeutics
ESPR
$7K ﹤0.01%
145
– –
FATE icon
1006
Fate Therapeutics
FATE
$281M
$7K ﹤0.01%
+550
New +$7.67K
IDCC icon
1007
PUT
InterDigital
IDCC
$6.68B
$7K ﹤0.01%
+227
New +$16.5K
RGNX icon
1008
Regenxbio
RGNX
$623M
$7K ﹤0.01%
172
– –
UBX
1009
DELISTED
Unity Biotechnology
UBX
$7K ﹤0.01%
+40
New +$5.31K
DCPH
1010
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$7K ﹤0.01%
+330
New +$8.11K
AERI
1011
DELISTED
Aerie Pharmaceuticals
AERI
$7K ﹤0.01%
203
– –
AIMT
1012
DELISTED
Aimmune Therapeutics
AIMT
$7K ﹤0.01%
281
– –
PTLA
1013
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$7K ﹤0.01%
361
– –
ZGNX
1014
DELISTED
Zogenix, Inc.
ZGNX
$7K ﹤0.01%
189
– –
ACIU icon
1015
AC Immune
ACIU
$227M
$6K ﹤0.01%
+600
New +$5.67K
ARWR icon
1016
Arrowhead Research
ARWR
$12.1B
$6K ﹤0.01%
477
– –
LKFT
1017
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$6K ﹤0.01%
60
– –
HCM icon
1018
HUTCHMED
HCM
$1.89B
$6K ﹤0.01%
+280
New +$8.7K
INSM icon
1019
Insmed
INSM
$23.2B
$6K ﹤0.01%
423
– –
PRQR icon
1020
ProQR Therapeutics
PRQR
$243M
$6K ﹤0.01%
+350
New +$6.42K
RCKT icon
1021
Rocket Pharmaceuticals
RCKT
$348M
$6K ﹤0.01%
+400
New +$6.64K
SIGA icon
1022
SIGA Technologies
SIGA
$223M
$6K ﹤0.01%
+800
New +$4.57K
VNDA icon
1023
Vanda Pharmaceuticals
VNDA
$312M
$6K ﹤0.01%
248
– –
ZLAB icon
1024
Zai Lab
ZLAB
$2.17B
$6K ﹤0.01%
+250
New +$4.64K
CBAY
1025
DELISTED
Cymabay Therapeutics
CBAY
$6K ﹤0.01%
+700
New +$6.66K
39 40
41
42 43

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2018 Portfolio in Review

As of Q4 2018, Daiwa Securities Group held 1,239 positions worth $10.4B, down 13% from $11.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $723M in Q4 2018, closing 97 positions and reducing 278 holdings. Its most notable exit was Steris, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in SITE Centers worth $138M.

  • Daiwa Securities Group's largest Q4 2018 buy was SITE Centers: 16,021,815 shares worth $138M.
  • Daiwa Securities Group added most to American Tower in Q4 2018, an estimated $128M increase.
  • Daiwa Securities Group's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $211M.
  • Daiwa Securities Group fully exited Steris in Q4 2018, selling an estimated $11.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2018.
  • Daiwa Securities Group opened 73 new positions and closed 97 in Q4 2018.
  • Daiwa Securities Group's portfolio value fell 13% quarter-over-quarter to $10.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.